Evidence map›Paper›PMID 38864072›Full record

ReviewCureus2024

Predicting the Progression of Chronic Kidney Disease: A Systematic Review of Artificial Intelligence and Machine Learning Approaches.

Fizza Khalid, Lara Alsadoun, Faria Khilji, Maham Mushtaq, Anthony Eze-Odurukwe, Muhammad Muaz Mushtaq, Husnain Ali, Rana Omer Farman, Syed Momin Ali, Rida Fatima and 1 more

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fizza KhalidNephrology, Sharif Medical City Hospital, Lahore, PAK.
Lara AlsadounTrauma and Orthopedics, Chelsea and Westminster Hospital, London, GBR.
Faria KhiljiInternal Medicine, Tehsil Headquarter Hospital, Shakargarh, PAK.
Maham MushtaqMedicine and Surgery, King Edward Medical University, Lahore, PAK.
Anthony Eze-OdurukweSurgery, Salford Royal NHS Foundation Trust, Manchester, GBR.
Muhammad Muaz MushtaqMedicine and Surgery, King Edward Medical University, Lahore, PAK.
Husnain AliMedicine and Surgery, King Edward Medical University, Lahore, PAK.
Rana Omer FarmanMedicine and Surgery, King Edward Medical University, Lahore, PAK.
Syed Momin AliMedicine and Surgery, King Edward Medical University, Lahore, PAK.
Rida FatimaMedicine and Surgery, Fatima Jinnah Medical University, Lahore, PAK.
Syed Faqeer Hussain BokhariSurgery, King Edward Medical University, Lahore, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is a progressive condition characterized by gradual loss of kidney function, necessitating timely monitoring and interventions. This systematic review comprehensively evaluates the application of artificial intelligence (AI) and machine learning (ML) techniques for predicting CKD progression. A rigorous literature search identified 13 relevant studies employing diverse AI/ML algorithms, including logistic regression, support vector machines, random forests, neural networks, and deep learning approaches. These studies primarily aimed to predict CKD progression to end-stage renal disease (ESRD) or the need for renal replacement therapy, with some focusing on diabetic kidney disease progression, proteinuria, or estimated glomerular filtration rate (GFR) decline. The findings highlight the promising predictive performance of AI/ML models, with several achieving high accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve scores. Key factors contributing to enhanced prediction included incorporating longitudinal data, baseline characteristics, and specific biomarkers such as estimated GFR, proteinuria, serum albumin, and hemoglobin levels. Integration of these predictive models with electronic health records and clinical decision support systems offers opportunities for timely risk identification, early interventions, and personalized management strategies. While challenges related to data quality, bias, and ethical considerations exist, the reviewed studies underscore the potential of AI/ML techniques to facilitate early detection, risk stratification, and targeted interventions for CKD patients. Ongoing research, external validation, and careful implementation are crucial to leveraging these advanced analytical approaches in clinical practice, ultimately improving outcomes and reducing the burden of CKD.

Indexed as

artificial intelligencechronic kidney diseasedisease progressionmachine learningpredictionsystematic review

Identifiers

PMID38864072
PMCPMC11166249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.